
Sign up to save your podcasts
Or


Dr. Marc Braunstein from NYU Langone joins the Healthcare Unfiltered EXPRESS to describe the recently published BRUIN-313 trial in frontline CLL and its potential impact on the treatment landscape for this disease. Check it out, subscribe, share, and join the conversation.
By Chadi NabhanDr. Marc Braunstein from NYU Langone joins the Healthcare Unfiltered EXPRESS to describe the recently published BRUIN-313 trial in frontline CLL and its potential impact on the treatment landscape for this disease. Check it out, subscribe, share, and join the conversation.